Skip to content

Mark Fesen, MD

NPI 1639149545ActiveIndividual· Internal Medicine, Medical Oncology· Great Bend, KS

Internal Medicine, Medical Oncology (MD) in Great Bend, Kansas, trained at Rutgers New Jersey Medical School (class of 1987). In 2024 Medicare paid $3,791,130 for 672 patients, and Part D covered 1,536 of their prescriptions, 84% of them generic. Pfizer Inc. was the largest of 38 companies reporting payments in 2025, $2,735 in all, mostly food and beverage.

Overview

NPI1639149545
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJan 24, 2006
Last updated in NPPESOct 10, 2024
Certified by providerOct 10, 2024

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Medical Oncology Primary207RX0202X04-24425KS

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Medical Oncology (KS)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients672
Services billed266,957 across 130 procedure codes
Paid by Medicare$3,791,130

Part D prescriptions in 2024

Prescriptions (claims)1,536 · 1,958 30-day fills
Patients199
Total drug cost$2,801,938
Generic share84% of claims

Medicare sources and data years

Education and affiliations

Medical schoolRutgers New Jersey Medical School
Graduation year1987
Medicare specialtyMedical Oncology
TelehealthOffers telehealth

Medical group

Hospital affiliations

Source: CMS Care Compare

Industry payments (Open Payments)

  • 2025$2,735 · 151 payments from 38 companies
  • 2024$1,896 · 105 payments from 37 companies

Top paying companies in 2025

CompanyAmountPayments
Pfizer Inc.$245.7525
Gilead Sciences, Inc.$193.256
Astrazeneca Pharmaceuticals LP$161.108
Abbvie Inc.$142.079
Janssen Biotech, Inc.$138.6912

What the 2025 payments were for

  • Food and Beverage$2,635 · 150 payments
  • Education$99.99 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records